PINRAL 200 MG 30 CHEWABLE TABLET – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for PINRAL 200 MG 30 CHEWABLE TABLET, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: PINRAL 200 MG 30 CHEWABLE TABLET

Manufacturer: SANOVEL PHARMACEUTICAL INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

LAMOTRIJIN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

PINRAL 200 MG 30 CHEWABLE TABLET is formulated with LAMOTRIJIN, a clinically established agent in medical practice.

  • Mechanism of Action: LAMOTRIJIN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to LAMOTRIJIN therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name PINRAL 200 MG 30 CHEWABLE TABLET
Barcode (GTIN) 8699536070056
Generic Name LAMOTRIJIN
License Holder SANOVEL PHARMACEUTICAL INDUSTRY AND TRADE INC.
Pharmacy Retail Price 429.96 TL
⚠️ Clinical Safety Warning

Do not administer PINRAL 200 MG 30 CHEWABLE TABLET if the patient has a known hypersensitivity or allergy to LAMOTRIJIN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via SANOVEL PHARMACEUTICAL INDUSTRY AND TRADE INC..

Leave a Comment